Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar plus Etoposide-Carboplatin in ED-SCLC
NCT00912392Phase 2Completed
- Sponsor
- Simcere Pharmaceutical Group
- Start
- May 2009
- Primary completion
- Dec 2012
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in small cell lung cancer (SCLC), sponsored by Simcere Pharmaceutical Group. Started May 2009; status: completed.
02
Drugs
endostar
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00912392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00912392.